Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Stakeholders' Perspectives on Current Issues in Data Monitoring Committees
Cartwright, Michael J., Friede, Tim, Lawrence, David, May, Emma, Mütze, Tobias, Roes, Kit
Published in Biometrical journal (01.10.2024)
Published in Biometrical journal (01.10.2024)
Get full text
Journal Article
Responsibilities of Data Monitoring Committees: Consensus Recommendations
Bierer, Barbara E., Li, Rebecca, Seltzer, Jonathan, Sleeper, Lynn A., Frank, Elizabeth, Knirsch, Charles, Aldinger, Carmen E., Levine, Robert J., Massaro, Joe, Shah, Amish, Barnes, Mark, Snapinn, Steven, Wittes, Janet
Published in Therapeutic innovation & regulatory science (01.09.2016)
Published in Therapeutic innovation & regulatory science (01.09.2016)
Get full text
Journal Article
Approach to the state of the art of data monitoring committees in clinical trials
Sonia Pérez Rodríguez, Héctor Lázaro Lara Fernández, Selma Arteaga Cantón, Meiby de la Caridad Rodríguez González, Maura Tamayo Rodríguez
Published in Revista cubana de medicina militar (01.01.2021)
Get full text
Published in Revista cubana de medicina militar (01.01.2021)
Journal Article
Returning Individual Research Results to Participants: Guidance for a New Research Paradigm
Downey, Autumn S, Busta, Emily R, Mancher, Michelle, Botkin, Jeffrey R
Year of Publication 20.08.2018
Year of Publication 20.08.2018
Get full text
eBook
Data and Safety Monitoring Boards: Academic Credit Where Credit Is Due?
Armstrong, Paul W, Califf, Robert M
Published in JAMA : the journal of the American Medical Association (16.10.2013)
Published in JAMA : the journal of the American Medical Association (16.10.2013)
Get full text
Journal Article
Improving the quality of drug research or simply increasing its cost? An evidence‐based study of the cost for data monitoring in clinical trials
Pronker, Esther, Geerts, Bart F., Cohen, Adam, Pieterse, Herman
Published in British journal of clinical pharmacology (01.03.2011)
Published in British journal of clinical pharmacology (01.03.2011)
Get full text
Journal Article
Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands
van den Bogert, Cornelis A., Souverein, Patrick C., Brekelmans, Cecile T.M., Janssen, Susan W.J., Koëter, Gerard H., Leufkens, Hubert G.M., Bouter, Lex M.
Published in Journal of clinical epidemiology (01.08.2017)
Published in Journal of clinical epidemiology (01.08.2017)
Get full text
Journal Article